Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mariela
Mariela Bollati-Fogolin, Braunschweig DE
| Patent application number | Description | Published |
|---|---|---|
| 20100028298 | INTERFERON TYPE I SUPPORTING COMPOUNDS - The present invention relates to the use of cyclic peptides, in particular of vioprolides for the treatment and prevention of various diseases, disorders and conditions. In particular, the present invention provides compounds useful in enhancing and/or supporting interferon type I1 like interferon alpha or interferon beta, treatment or prevention of diseases, disorders or conditions. Further, the present invention relates to new pharmaceutical compositions comprising specific cyclic peptides, in particular, vioprolides, and type I interferon and its use in the treatment of various diseases, in particular, in the treatment or prevention of infectious diseases, cancers etc. Finally, the present invention provides methods for preventing or treating diseases, disorders or conditions susceptible to type I interferon treatment or prevention. | 02-04-2010 |
Mariela Carpinella, Cordoba AR
| Patent application number | Description | Published |
|---|---|---|
| 20110109308 | MAGNETIC RESONANCE BASED APPARATUS AND METHOD TO ANALYZE AND TO MEASURE THE BI-DIRECTIONAL FLOW REGIME IN A TRANSPORT OR A PRODUCTION CONDUIT OF COMPLEX FLUIDS, IN REAL TIME AND REAL FLOW-RATE - A method for determining individual component flow-rates in a multi-phase fluid flowing in a pipe comprises the steps of: a) flowing the fluid through a magnetic resonance based apparatus comprising a magnetic resonance module and at least one pre-polarization module through which the fluid phases flow before entering the magnetic resonance module, wherein said pre-polarization module comprises a plurality of cylindrical segments that can be selectively combined so as to modify the effective length of the pre-polarization module, b) selectively using the prepolarization module to polarize a component in a volume of the fluid, c) applying a selective excitation to said fluid volume, d) using a signal resulting from said excitation to obtain a velocity measurement for said component, and e) repeating steps b)-d) until velocity measurements for a desired number of components have been obtained. | 05-12-2011 |
Mariela Colón, Collegeville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090082357 | Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I) | 03-26-2009 |
| 20100305133 | Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain quinoxaline-5-carboxamide derivatives of formula (I) | 12-02-2010 |
Mariela Gauto, Bradford GB
| Patent application number | Description | Published |
|---|---|---|
| 20100175845 | Aqueous Solutions Of Optical Brighteners - The instant invention relates to storage stable aqueous optical brightener/PVOH solutions of low viscosity which may be used directly by the papermaker, in that they can be metered by pump directly into a coating composition, and which provide coated papers of a surprisingly high whiteness | 07-15-2010 |
| 20100181536 | Aqueous Solutions of Optical Brighteners - The instant invention relates to storage stable aqueous optical brightener/PVOH solutions of low viscosity which may be used directly by the papermaker, in that they can be metered by pump directly into a coating composition, and which provide coated papers of a surprisingly high whiteness | 07-22-2010 |
Mariela Gauto, Leeds GB
| Patent application number | Description | Published |
|---|---|---|
| 20090081475 | Aqueous Solutions of Optical Brighteners - The instant invention relates to storage stable aqueous solutions of stilbene optical brighteners with polyvinyl alcohols which can be directly used by the papermaker in that they may be diluted with water and/or be metered directly into a coating composition, to provide coated papers of a particularly high whiteness. | 03-26-2009 |
Mariela Horzella Rademacher, Valdivia CL
| Patent application number | Description | Published |
|---|---|---|
| 20100239561 | SURFACE SANITIZER FOR THE FOOD INDUSTRY BASED ON THREE NEW LACTIC ACID BACTERIA THAT HAVE ANTAGONISTIC ACTION AGAINST Listeria monocytogenes, THE MICROORGANISM THAT CAUSES LISTERIOSIS IN HUMANS - The present invention relates to a formulation useful to control | 09-23-2010 |
Mariela Todorova, Sofia BG
| Patent application number | Description | Published |
|---|---|---|
| 20090282401 | DEPLOYING SOFTWARE MODULES IN COMPUTER SYSTEM - Methods and systems are disclosed herein for deploying software modules in a computer system. In one embodiment, a number of containers are registered with a deployer. At least one container provides runtime environment for a corresponding type of software module in the computer system. The software modules are one of standalone software modules and components of software applications. From an archive file a number of files that include deployable software modules are extracted. The software modules corresponding to at least one of the containers are detected based on container specific detecting mechanisms. The detected software modules are validated in order to test their functionality and interoperability. When the software modules are validated, they are distributed for implementation in the corresponding containers. | 11-12-2009 |
Mariela Vazquez Castillo, Ciudad De La Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20090221512 | PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 TO PREVENT AND ELIMINATE FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUES - The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma. | 09-03-2009 |